CbdMD, Inc.
YCBD
Rank in Stocks
#30808
cbdMD, Inc. is engaged in the production and distribution of a diverse array of... cbdMD, Inc. is engaged in the production and distribution of a diverse array of cannabidiol (CBD) products. The company oversees and markets several consumer-oriented, hemp-derived CBD brands, notably its primary brand cbdMD, alongside Paw CBD and cbdMD Botanicals. Under the cbdMD label, its offerings span various items, including CBD tinctures, edible gummies, topical applications, capsules, bath bombs, bath salts, and solutions designed to aid sleep. Furthermore, its Paw CBD brand caters to pets with veterinarian-formulated products such as tinctures, edible chews, and topical treatments. The company's merchandise reaches customers throughout the United States via its proprietary e-commerce platform, various third-party online retail sites, wholesale partners, and physical brick-and-mortar establishments. cbdMD, Inc. also maintains a research collaboration with the University of Mississippi, focusing on the discovery of novel cannabinoids. Incorporated in 2015, the firm was previously known as Level Brands, Inc. before officially changing its name to cbdMD, Inc. in May 2019, and its corporate headquarters are situated in Charlotte, North Carolina.
Share Price
$0.381
Last synced: 2026-11-09
Market Cap
$4.27M
Change (1 day)
-8.41%
Change (1 year)
-48.37%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade CbdMD, Inc. (YCBD)
Category
Healthcare
Operating Margin for CbdMD, Inc. (YCBD)
Operating Margin as of November 2026 TTM: -13.87%
According to CbdMD, Inc.'s latest financial reports, its current operating margin (TTM) is -13.87%. At the end of 2025 the company had an operating margin of -11.27%.
Operating Margin history for CbdMD, Inc. from 2015 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -13.87% | 23.07% |
| 2025 | -11.27% | -31.15% |
| 2024 | -16.37% | -57.34% |
| 2023 | -38.37% | -21.53% |
| 2022 | -48.90% | 10.88% |
| 2021 | -44.10% | 5.05% |
| 2020 | -41.98% | -30.86% |
| 2019 | -60.72% | -84.49% |
| 2018 | -391.44% | 7,216.64% |
| 2017 | -5.35% | -97.09% |
| 2016 | -183.76% | 0.00% |
| 2015 | 0.00% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 19.41% | -101.40% |
DE
|
|
| 19.68% | -101.42% |
DE
|
|
| 13.26% | -100.96% |
JP
|
|
| 17.08% | -101.23% |
CH
|
|
| 14.92% | -101.08% |
IL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about CbdMD, Inc.'s operating margin
What is CbdMD, Inc.'s operating margin?
CbdMD, Inc.'s operating margin is -13.87%, as of Nov 2026.
What was CbdMD, Inc.'s operating margin in 2025?
In 2025, CbdMD, Inc.'s operating margin was -11.27%, compared with -16.37% in 2024.
How has CbdMD, Inc.'s operating margin changed since 2020?
From 2020 to 2025, CbdMD, Inc.'s operating margin was highest in 2025 (-11.27%) and lowest in 2022 (-48.90%).
How does CbdMD, Inc.'s operating margin compare with similar companies?
CbdMD, Inc.'s operating margin (-13.87%) is lower than that of all 5 similar companies listed above. The highest among them is Merck KGaA, with 19.68%.